Association of physical activity with mortality in chronic kidney disease.

Abstract:

BACKGROUND:Chronic kidney disease (CKD) is an important risk factor for all-cause mortality. In the general population, physical activity is associated with reduced mortality. We examined the association of level of physical activity with mortality in patients with predominantly nondiabetic CKD stage 3-4. METHODS:We studied 811 patients with CKD enrolled in the Modification of Diet in Renal Disease (MDRD) Study, a multicenter clinical trial conducted between 1989 and 1993. Patients completed a survey of their physical activity at baseline, from which we derived 3 physical activity variables: indoor activity, exercise and outdoor activity, using standardized scores. We used Cox proportional hazards modeling to examine the relationship between baseline physical activity and all-cause mortality with long-term outcome ascertained through 2000. RESULTS:The mean age of the study population was 52 years, and 61% were male. The mean glomerular filtration rate was 32.5 ml/min per 1.73 m2. A total of 24.6% died during follow-up. After adjustment for other factors significantly associated with mortality, the hazard ratio for all-cause mortality for indoor activity was 0.94 (95% confidence interval [95% CI], 0.77-1.14), exercise 1.01 (95% CI, 0.84-1.10) and outdoor activity 0.94 (95% CI, 0.80-1.10). CONCLUSIONS:Higher levels of physical activity were not significantly associated with a reduction in long-term mortality in patients with CKD in this cohort. Additional prospective studies are needed to confirm our finding and determine whether physical activity improves outcomes in patients with CKD.

journal_name

J Nephrol

journal_title

Journal of nephrology

authors

Chen JL,Lerner D,Ruthazer R,Castaneda-Sceppa C,Levey AS

subject

Has Abstract

pub_date

2008-03-01 00:00:00

pages

243-52

issue

2

eissn

1121-8428

issn

1724-6059

journal_volume

21

pub_type

杂志文章,多中心研究,随机对照试验
  • Page kidney--a review of the literature.

    abstract::Page kidney was first described in animal experiments in 1939. In the 1950s and 1960s the human counterpart became evident. In this review we examine the modest literature on this rare but important renal/urological complication, summarize the clinical features, and discuss the best approach to diagnosis and managemen...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Haydar A,Bakri RS,Prime M,Goldsmith DJ

    更新日期:2003-05-01 00:00:00

  • Leon Marchlewski: one of the precursors of clinical chemistry.

    abstract::Dynamic progress in the basic sciences such as clinical chemistry exerted a great influence on the development of clinical science in medicine in the 19th century. We should rate Prof. Leon Marchlewski among the group of prominent foreign and Polish scientists working in that period. Marchlewski was born in 1869 in Wl...

    journal_title:Journal of nephrology

    pub_type: 传,历史文章,杂志文章

    doi:10.5301/JN.2011.6454

    authors: Ostrowski J,Muszytowski M,Rutkowski B

    更新日期:2011-05-01 00:00:00

  • Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.

    abstract:BACKGROUND:The recent multicenter, randomized, open-label INDEPENDENT study demonstrated that sevelamer improves survival in new to hemodialysis (HD) patients compared with calcium carbonate. The objective of this study was to determine the cost-effectiveness of sevelamer versus calcium carbonate for patients new to HD...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1007/s40620-014-0122-8

    authors: Ruggeri M,Bellasi A,Cipriani F,Molony D,Bell C,Russo D,Di Iorio B

    更新日期:2015-10-01 00:00:00

  • Preemptive liver transplantation in primary hyperoxaluria type 1: timing and preliminary results.

    abstract::Preemptive isolated liver transplantation (PLTX) can cure the metabolic defect in primary hyperoxaluria type 1 (PH1) but there are no uniformally accepted recommendations concerning the timing of this transplantation procedure. We have performed PLTX successfully in 4 children (age 3-9 years) with PH1 with no mortalit...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Kemper MJ,Nolkemper D,Rogiers X,Timmermann K,Sturm E,Malago M,Broelsch CE,Burdelski M,Müller-Wiefel DE

    更新日期:1998-03-01 00:00:00

  • Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction.

    abstract:BACKGROUND:This study investigated whether modifications of placental expression of endothelin-1 (ET-1), nitric oxide synthase (NOS) and tissue factor (TF) are associated with abnormal Doppler waveforms. METHODS:Fourteen pre-term severe preeclamptic (PE) women with fetal growth restriction (FGR) and 14 normal preg nan...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Di Paolo S,Volpe P,Grandaliano G,Stallone G,Schena A,Greco P,Resta L,Selvaggi L,Cincione R,Schena FP,Gesualdo L

    更新日期:2003-09-01 00:00:00

  • Lymphocyte costimulatory receptors in renal disease and transplantation.

    abstract::Cell-to-cell signal exchange during antigen presentation deeply influences the profile and extent of the immune response. Together with the TCR/MHC-mediated signal, accessory signals are provided to the T cell by the antigen-presenting cell (APC), through specific receptor-ligand interactions that represent indispensa...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Biancone L,Deambrosis I,Camussi G

    更新日期:2002-01-01 00:00:00

  • Clinical manifestations of systemic paraphenylene diamine intoxication.

    abstract:BACKGROUND:To report clinical symptoms and outcome of systemic paraphenylene diamine (PPD) intoxication. METHODS:Our study was retrospective. It was conducted over 6 yrs (1994-2000) in the medical intensive care unit (ICU) of a university hospital and it concerned 19 patients hospitalized for systemic PPD intoxication...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Kallel H,Chelly H,Dammak H,Bahloul M,Ksibi H,Hamida CB,Chaari A,Rekik N,De Broe ME,Bouaziz M

    更新日期:2005-05-01 00:00:00

  • Peroxynitrite plays a key role in glomerular lesions in diabetic rats.

    abstract:BACKGROUND:Oxidative stress plays a crucial role in chronic complications of diabetes such as diabetic nephropathy (DN), the main cause of renal failure. In diabetes, whether peroxynitrite (ONOO(-)), generated from inducible nitric oxide synthase (iNOS) induced by tumor necrosis factor alpha (TNF-alpha), plays a primar...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Xiao H,Li Y,Qi J,Wang H,Liu K

    更新日期:2009-11-01 00:00:00

  • Calcium mass balances during standard bicarbonate hemodialysis and long-hour slow-flow bicarbonate hemodialysis.

    abstract:BACKGROUND:Dialysate calcium (Ca) concentration should be viewed as part of the integrated therapeutic regimen to control renal osteodystrophy and maintain normal mineral metabolism. Thus, a correct ionized calcium mass balance (Ca++MB) during hemodialysis (HD) is crucial in the treatment of renal osteodystrophy. The G...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,随机对照试验

    doi:10.5301/JN.2011.6385

    authors: Basile C,Libutti P,Di Turo AL,Tundo S,Maselli P,Casucci F,Losurdo N,Teutonico A,Vernaglione L,Lomonte C

    更新日期:2011-11-01 00:00:00

  • Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease.

    abstract::Ferumoxytol is a new product approved for intravenous use by the US Food and Drug Administration (FDA) in the treatment of iron deficiency anemia in adults with chronic kidney disease. This approval was based on data from 3 open-label, randomized, controlled clinical trials. In all of these trials, ferumoxytol was wel...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/jn.5000025

    authors: Kowalczyk M,Banach M,Rysz J

    更新日期:2011-11-01 00:00:00

  • Active compounds extracted from extra virgin olive oil counteract mesothelial-to-mesenchymal transition of peritoneal mesothelium cells exposed to conventional peritoneal dialysate: in vitro and in vivo evidences.

    abstract::During peritoneal dialysis (PD), peritoneal mesothelial cells undergo a transition from an epithelial phenotype to a mesenchymal phenotype that, together with the inflammatory process, promotes tissue fibrosis and a failure of peritoneal membrane function. To date, there is no definitive treatment for the progressive ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-016-0368-4

    authors: Lupinacci S,Toteda G,Vizza D,Perri A,Benincasa C,Mollica A,La Russa A,Gigliotti P,Leone F,Lofaro D,Bonofiglio M,Perri E,Bonofiglio R

    更新日期:2017-12-01 00:00:00

  • Na+:HCO3- cotransporters (NBC): expression and regulation in the kidney.

    abstract::Recent molecular cloning experiments have identified the existence of four NBC isoforms (NBC1, 2, 3 and 4) and two NBC-related proteins AE4 and NCBE (Anion Exchanger 4 and Sodium-dependent Chloride-Bicarbonate Exchanger). Except for AE4 which does not transport Na, all are presumed to mediate the cotransport of Na+ an...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Soleimani M

    更新日期:2002-03-01 00:00:00

  • Treatment of reduced bone density with ibandronate in dialysis patients.

    abstract::Bisphosphonates inhibit bone resorption and are widely used to treat osteolytic metastases and osteoporosis. Renal osteodystrophy patients have continuous bone loss due to chronically elevated parathyroid hormone (PTH). In this open-label study, ibandronate was evaluated for the treatment of reduced bone density in re...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,随机对照试验

    doi:

    authors: Bergner R,Henrich D,Hoffmann M,Schmidt-Gayk H,Lenz T,Upperkamp M

    更新日期:2008-07-01 00:00:00

  • Further insights about the beneficial effects of n-3 fatty acids in the early molecular events of renal fibrosis in vitro.

    abstract:BACKGROUND:Accumulating experimental and clinical evidence reveals beneficial effects of n-3 polyunsaturated fatty acids (PUFAs) in kidney disease by modulating inflammation and fibrosis mechanisms that lead to renal failure. METHODS:EPA, DHA (n-3 PUFAs) and AA (n-6 PUFA) effects, compared to those of AngII, on renal ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.5301/jn.5000193

    authors: Priante G,Musacchio E,Valvason C,Clari G,Bordin L,Sartori L,Baggio B

    更新日期:2013-07-01 00:00:00

  • Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia-reperfusion induced kidney injury.

    abstract:BACKGROUND:Ischemia-reperfusion (IR) causes acute kidney injury (AKI), and ischemia pretreatment may exert protection. Mitogen-activated protein kinase kinase 3 (MKK3), which is involved in the signal transduction pathway in IR-induced injury, is a potential target of miR-21. We aimed to verify the targeting regulation...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-015-0217-x

    authors: Li Z,Deng X,Kang Z,Wang Y,Xia T,Ding N,Yin Y

    更新日期:2016-02-01 00:00:00

  • Salt intake and hypertension therapy.

    abstract::Hypertension is a risk factor for cardiovascular and renal organ damage. Environmental conditions affect the development of high blood pressure (BP), although genetic influences are also important. Current international guidelines recommend reducing dietary sodium to no more than 100 mmol (about 2.4 g sodium or approx...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Milan A,Mulatero P,Rabbia F,Veglio F

    更新日期:2002-01-01 00:00:00

  • Calciphylaxis: from the disease to the diseased.

    abstract::Calciphylaxis, or calcific uremic arteriolopathy, is a vascular ossification-calcification disease involving cutaneous or visceral arterioles, with ischemic damage of the surrounding tissues, usually in the setting of chronic kidney disease. Pathogenesis is still unclear and probably comprises the participation of vas...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-015-0192-2

    authors: Oliveira TM,Frazão JM

    更新日期:2015-10-01 00:00:00

  • Fibroblast growth factor 23: are we ready to use it in clinical practice?

    abstract::Patients with chronic kidney disease (CKD) have a greatly enhanced risk of cardiovascular morbidity and mortality. Over the past decade it has come clear that a disturbed calcium-phosphate metabolism, with Fibroblast Growth Factor-23 as a key hormone, is partly accountable for this enhanced risk. Numerous studies have...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-020-00715-2

    authors: Bouma-de Krijger A,Vervloet MG

    更新日期:2020-06-01 00:00:00

  • Inadvertent sodium loading with renal replacement therapy in critically ill patients.

    abstract:BACKGROUND:Inadvertent sodium (Na(+)) flux may occur during renal replacement therapy (RRT) in ICU. The objective of this study was to estimate sodium flux during RRT. METHODS:Between September 2011 to December 2012 we studied 60 ICU patients receiving extended daily dialysis (EDD, Fresenius 4008S) or continuous renal...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-014-0041-8

    authors: Bihari S,Taylor S,Bersten AD

    更新日期:2014-08-01 00:00:00

  • Spontaneous coronary artery dissection: One more extrarenal manifestation of autosomal dominant polycystic kidney disease?

    abstract::Autosomal dominant polycystic kidney disease (ADPKD) may present with a variety of extrarenal manifestations. Only 1 case of spontaneous coronary artery dissection has been reported so far in ADPKD. Here we report a case of coronary artery dissection occurring in a 38-year-old woman with ADPKD and an unremarkable medi...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Basile C,Lucarelli K,Langialonga T

    更新日期:2009-05-01 00:00:00

  • The continuous challenge of cardiovascular and bone and bone disease in uremic patients: clinical consequences of hyperphosphatemia and advanced therapeutic approaches.

    abstract::This review focuses on a series of risk factors involved in the pathogenesis of cardiovascular complications in patients undergoing Regular Dialysis Treatment (RDT). Many of them are not modifiable by any pharmacological strategies or dialysis therapy, others - such as phosphate overload - can be corrected successfull...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Brancaccio D,Zoccali C

    更新日期:2006-01-01 00:00:00

  • Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis.

    abstract:INTRODUCTION:End stage renal disease (ESRD) is associated with a high incidence of cardiovascular disease and cancer. Patients undergoing hemodialysis show a reduced number and an impaired function of endothelial progenitor cells (EPCs), which in physiological conditions contribute to repair the vascular damage. In pat...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Buemi M,Costa C,Floccari F,Coppolino G,Campo S,Bolignano D,Sturiale A,Lacquaniti A,Buemi A,Loddo S,Teti D

    更新日期:2010-05-01 00:00:00

  • Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study.

    abstract::Highly concentrated marine polyunsaturated fatty acids (n-3 PUFA), affecting the lipids and lipophilic drugs metabolism, can interfere with cyclosporine (CyA) pharmacokinetics. This prospective, randomized and placebo-controlled, double-blind study involved 42 kidney graft recipients. From day +1, 21 pts (E) received ...

    journal_title:Journal of nephrology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Busnach G,Stragliotto E,Minetti E,Perego A,Brando B,Broggi ML,Civati G

    更新日期:1998-03-01 00:00:00

  • Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.

    abstract:BACKGROUND:Functional failure of the peritoneal membrane is the most serious problem in long-term continuous ambulatory peritoneal dialysis (CAPD). Transforming growth factor-beta (TGF-ss) is one of the key mediators of fibrosis in some organs, and is thought to be involved in peritoneal alterations. In this study, we ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Naiki Y,Maeda Y,Matsuo K,Yonekawa S,Sakaguchi M,Iwamoto I,Hasegawa H,Kanamaru A

    更新日期:2003-01-01 00:00:00

  • Three-dimensional contrast-enhanced magnetic resonance angiography (3-D CE-MRA) in the evaluation of hemodialysis access complications, and the condition of central veins in patients who are candidates for hemodialysis access.

    abstract:BACKGROUND:Arteriovenous (AV) fistulas are crucial in patients requiring long-term hemodialysis (HD). Dysfunctions of these fistulas are the most common causes of recurrent hospitalizations. This study aimed to evaluate the feasibility, safety and usefulness of contrast-enhanced magnetic resonance angiography (CE-MRA) ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Paksoy Y,Gormus N,Tercan MA

    更新日期:2004-01-01 00:00:00

  • Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.

    abstract::Hyperlipidaemia complicating the nephrotic syndrome is characterised by elevated levels of total and LDL cholesterol, often with hypertriglyceridaemia and low HDL cholesterol levels. The underlying mechanisms are complex but involve abnormalities of both lipoprotein synthesis and catabolism. Experience to date suggest...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Wheeler DC

    更新日期:2001-11-01 00:00:00

  • Effect of water composition and timing of ingestion on urinary lithogenic profile in healthy volunteers: a randomized crossover trial.

    abstract::Kidney stone disease is a common condition with a high recurrence rate and elevated costs. Despite the well-known positive effects of high fluid intake, there are little data about the roles of water composition and timing of ingestion during the day. This study examines the effect of two different waters [calcium-bic...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-020-00769-2

    authors: Ferraro PM,Baccaro R,Baroni S,D'Alessandri L,Carpenito C,Di Daniele N,Urbani A,Gambaro G

    更新日期:2020-06-08 00:00:00

  • IgA nephropathy and infections.

    abstract::In this paper we concentrate on the role of infections in IgA nephropathy both from a pathogenetic and clinic point of view. The current hypotheses as regards the role of infections in the pathogenesis of IgA nephropathy are: (a) role of particular pathogens, (b) chronic exposure to mucosal infections, (c) abnormal ha...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-016-0265-x

    authors: Rollino C,Vischini G,Coppo R

    更新日期:2016-08-01 00:00:00

  • Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?

    abstract::The partial correction of anemia and the normalization of phosphate and blood pressure are the mainstay of treatment of patients with chronic kidney disease (CKD). Available anti-hypertensive drugs, erythropoiesis stimulating agents (ESAs) and iron supplements have resolved quite satisfactorily the goal of controlling...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-017-0421-y

    authors: Locatelli F,Del Vecchio L

    更新日期:2017-12-01 00:00:00

  • Sodium removal and plasma tonicity balance are not different in hemodialysis and hemodiafiltration using high-flux membranes.

    abstract:BACKGROUND:The clinical benefits of on-line hemodiafiltration (HDF) versus high-flux membranes hemodialysis (hf-HD) are still debated. In fact, although a superiority of one treatment over the other, especially in terms of mortality, did not emerge from the analysis of clinical trials, improved intradialytic vascular s...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-018-00581-z

    authors: La Milia V,Ravasi C,Carfagna F,Alberghini E,Baragetti I,Buzzi L,Ferrario F,Furiani S,Barbone GS,Pontoriero G

    更新日期:2019-06-01 00:00:00